News archive

Mexidol® FORTE 250: the Expert Council members’ opinion of the therapeutic potential in the treatment of patients with cerebrovascular disease

In September, with the support of Vectorpharm LLC, an Expert Council of Neurologists and Clinical Pharmacologists was held, which was attended by leading Russian experts from Moscow, St. Petersburg, Novosibirsk, Volgograd, Kazan, Yaroslavl and other cities of Russia. The main topic was the discussion of medical application of a new form of domestic reference drug Mexidol® FORTE 250 in the dosage of 250 mg. The Council chairman and moderator was Professor A.I. Fedin.

Read More